Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

Cited by (208)

Items 101–200 of 208

1. The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
   Matthew T. J. Halma, Jessica Rose, Alan Jenks, Theresa Anne Lawrie · 2023 · J — Multidisciplinary Scientific Journal
2. Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
   Andrei A. Deviatkin, Ruslan A. Simonov, Kseniya A. Trutneva, Anna A. Maznina, Elena M. Khavina, Pavel Volchkov · 2022 · Vaccines
3. Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses
   Zihao Wang, Yanni Chen, Hongyue Wu, Min Wang, Li Mao, Xingdong Guo, Jianbo Zhu, Zilan Ye, Xiaoyan Luo, Xiurong Yang et al. · 2024 · Scientific Reports
4. Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection
   Verena Krähling, Stephanie Erbar, Alexandra Kupke, Sara S. Nogueira, Kerstin C. Walzer, Hendrik Berger, Erik Dietzel, Sandro Halwe, Cornelius Rohde, Lucie Sauerhering et al. · 2022 · Molecular Therapy
5. Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
   Alberto Rubio‐Casillas, David Cowley, Mikolaj Raszek, Vladimir Nikolaevich Uversky, Elrashdy M Moustafa Mohamed Redwan · 2024 · International Journal of Biological Macromolecules
6. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
   Pandey, Manish, Ojha, Divya, Bansal, Sakshi, Rode, Ambadas B., Chawla, Geetanjali · 2021 · Molecular Aspects of Medicine
7. Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems
   Jiaxuan Li, Yuning Zhang, Yong‐Guang Yang, Tianmeng Sun · 2024 · Molecular Pharmaceutics
8. COVID-19 Vaccine: Between Myth and Truth
   Pier Paolo Piccaluga, Antonio Di Guardo, Anna Lagni, Virginia Lotti, Erica Diani, Mohsen Navari, Davide Gibellini · 2022 · Vaccines
9. HIV and Messenger RNA Vaccine
   Khizer Khalid, Jaskamal Padda, Anwar Khedr, Dina Ismail, Ujala Zubair, Ola A Al-Ewaidat, Sandeep Padda, Ayden Charlene Cooper, Gutteridge Jean-Charles · 2021 · Cureus
10. The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity
    Stephanie M. Bates, Michael J. Munson, Vítor Trovisco, Sara G. T. Pereira, Sophie R. Miller, Alan Sabirsh, Catherine Jean Betts, Erik Oude Blenke, Nicholas J. Gay · 2025 · Journal of Controlled Release
11. An Insight into Nanomedicinal Approaches to Combat Viral Zoonoses
    Prasad Minakshi, Mayukh Ghosh, Rajesh Kumar, Basanti Brar, Upendra Pradeep Lambe, Somesh Banerjee, Koushlesh Ranjan, Balvinder Kumar, Parveen Goel, Yashpal Singh Malik et al. · 2020 · Current Topics in Medicinal Chemistry
12. Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
    Eugenia Ziying Ong, Jia Xin Yee, Justin S. G. Ooi, Ayesa Syenina, Ruklanthi de Alwis, Shiwei Chen, Jean Xiang Ying Sim, Shirin Kalimuddin, Yan Shan Leong, Yvonne F. Z. Chan et al. · 2022 · npj Vaccines
13. The Use of Lactose as an Alternative Coating for Nanoparticles
    Jamie L. Betker, Thomas J. Anchordoquy · 2020 · Journal of Pharmaceutical Sciences
14. Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells
    Helena Vanluchene, Oriane Gillon, Karen Peynshaert, Stefaan C. De Smedt, Niek N. Sanders, Koen Raemdonck, Katrien Remaut · 2024 · European Journal of Pharmaceutics and Biopharmaceutics
15. Improving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA
    Hanne Huysmans, Joyca De Temmerman, Zifu Zhong, Séan Mc Cafferty, Francis Combes, Freddy Haesebrouck, Niek N. Sanders · 2019 · Molecular Therapy — Nucleic Acids
16. Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV
    Sigrid D’haese, Céline Lacroix, Felipe García, Montserrat Plana, Simona Maria Ruță, Guido L. Vanham, Bernard Verrier, Joeri L. Aerts · 2020 · Journal of Controlled Release
17. Nonclinical Safety Assessment of Lipid Nanoparticle-and Emulsion-Based Self-Amplifying mRNA Vaccines in Rats
    Douglas A. Donahue, Cristina Ballesteros, Giulietta Maruggi, Christiana Glover, Michael A. Ringenberg, Miriam Marquis, Nawel Ben Abdeljelil, Asma Ashraf, Luis-Alexander Rodriguez, Alan H. Stokes · 2022 · International Journal of Toxicology
18. RNA vaccines: The dawn of a new age for tuberculosis?
    Junli Li, Dong Liu, Xiaochi Li, Jiazheng Wei, Weixin Du, Aihua Zhao, Miao Xu · 2025 · Human Vaccines & Immunotherapeutics
19. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans
    Keshav Goyal, Harsh Goel, Pritika Baranwal, Anisha Tewary, Aman Dixit, Avanish Kumar Pandey, Mercilena Benjamin, Pranay Tanwar, Abhijit Dey, Fahad Khan et al. · 2021 · Immuno
20. Alphavirus-based replicons demonstrate different interactions with host cells and can be optimized to increase protein expression
    Francisco de Borja Pérez Domínguez, Oksana Palchevska, Elena I. Frolova, Ilya V. Frolov · 2023 · Journal of Virology
21. Respiratory delivered vaccines: Current status and perspectives in rational formulation design
    Lan Wu, Wenwen Xu, Huiyang Jiang, Mingshi Yang, Dongmei Cun · 2024 · Acta Pharmaceutica Sinica B
22. Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
    Chaoying Hu, Jianyang Liu, Feiran Cheng, Yu Bai, Qunying Mao, Miao Xu, Zhenglun Liang · 2023 · Frontiers in Immunology
23. Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine
    Sapna Sharma, Michael Schmid, Lorena Sánchez-Felipe, Jana Grenelle, Suzanne J. F. Kaptein, Lotte Coelmont, Johan H. Neyts, Kai Dallmeier · 2020 · Human Vaccines & Immunotherapeutics
24. The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels
    Hussein A Noureldine, Julian Maamari, Mohamad Othman El Helou, Georges Chedid, Anna Farra, Rola Husni, Jacques Mokhbat · 2022 · Immunologic Research
25. Current development of Zika virus vaccines with special emphasis on virus-like particle technology
    Velasco Cimica, Jose M. Galarza, Sujatha Rashid, Timothy T. Stedman · 2021 · Expert Review of Vaccines
26. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques
    Megan A. O’Connor, Jesse H. Erasmus, Samantha Randall, Jacob F. Archer, Thomas B. Lewis, Brieann Brown, Megan Fredericks, Skyler Groenier, Naoto Iwayama, Chul Y. Ahrens et al. · 2021 · Frontiers in Immunology
27. Advanced nanoscale delivery systems for mRNA-based vaccines
    Maha Mobasher, Rais Ahmad Ansari, Ana Maria Castejon, Jaleh Barar, Yadollah Omidi · 2024 · Biochimica et Biophysica Acta (BBA) - General Subjects
28. The Interplay Between Therapeutic Self-Amplifying RNA and the Innate Immune System: Balancing Efficiency and Reactogenicity
    Dmitry Kunyk, Marina A. Plotnikova, Mikhail Bespalov, Daniil Shevyrev, Sergey A. Klotchenko, Roman A. Ivanov, Vasiliy V. Reshetnikov · 2025 · International Journal of Molecular Sciences
29. Targeting the alphavirus virus replication process for antiviral development
    Yaw Bia Tan, Michelle Cheok Yien Law, Dahai Luo · 2022 · Antiviral Research
30. Zika virus NS4B protein targets TANK-binding kinase 1 and inhibits type I interferon production
    María B. Sarratea, Andrés Sánchez Alberti, Daniela María Redolfi, Sofía Noli Truant, Laura Valeria Iannantuono López, Augusto E. Bivona, Roy A. Mariuzza, Marisa Mariel Fernández, Emilio Luis Malchiodi · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
31. Controlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport
    Jason A. Wojcechowskyj, Robyn M. Jong, Imre Mäger, Britta Flach, Paul V. Munson, Progya P Mukherjee, Barbara Mertins, Katherine R Barcay, Thomas Folliard · 2025 · npj Vaccines
32. Clinical Development of mRNA Vaccines: Challenges and Opportunities
    Allison August, Luis Brito, Robert Paris, Tal Z. Zaks · 2022 · Current topics in microbiology and immunology
33. IL-10 modified mRNA monotherapy prolongs survival after composite facial allografting through the induction of mixed chimerism
    Ana Elena Aviña, Dante De Paz, Shu-Chun Huang, Kuan‐Hung Chen, Yun‐Ching Chang, Chin-Ming Lee, Chia-Hsien Lin, Fu‐Chan Wei, Aline Yen Ling Wang · 2023 · Molecular Therapy — Nucleic Acids
34. Research progress of mosquito-borne virus mRNA vaccines
    Ning Sun, Zhiwei Su, Xiaoyan Zheng · 2024 · Molecular Therapy — Methods & Clinical Development
35. Vaccines on demand, part II: future reality
    Geall, Andrew J., Kis, Zoltan, Ulmer, Jeffrey B. · 2023 · Expert Opinion on Drug Discovery
36. Towards mRNA therapeutics 2.0
    Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
37. Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
    Akina Nakamura, Tomohiro Kotaki, Yurie Nagai, Shunta Takazawa, Kenzo Tokunaga, Masanori Kameoka · 2022 · PLoS ONE
38. A duplex droplet digital PCR assay for absolute quantification and characterization of long self-amplifying RNA
    Irafasha C. Casmil, Cynthia Huang, Anna K. Blakney · 2023 · Scientific Reports
39. Tissue Tension and Strain as Indicators of Suction‐mediated Cutaneous DNA Transfection: A Parametric Study
    Nandita Chakrabarty Jhumur, Emran O. Lallow, Catherine J. Nachtigal, Dahee Yeo, Ijoo Kwon, Young K. Park, Christine C. Roberts, Jeffrey D. Zahn, David I. Shreiber, Jerry W. Shan et al. · 2024 · Advanced Therapeutics
40. Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
    Lorena Leonardelli, Giuseppe Lofano, Gianluca Selvaggio, Silvia Parolo, Stefano Giampiccolo, Danilo Tomasoni, Enrico Domenici, Corrado Priami, Haifeng Song, Duccio Medini et al. · 2021 · Frontiers in Immunology
41. Modified mRNA-Based Vaccines Against Coronavirus Disease 2019
    Aline Yen Ling Wang · 2022 · Cell Transplantation
42. Cap-independent co-expression of dsRNA-sensing and NF-κB pathway inhibitors enables controllable self-amplifying RNA expression with reduced immunotoxicity
    Tony K.Y. Lim, Anne Ritoux, Luke W Paine, Larissa Ferguson, Tawab Abdul, Laura J Grundy, Ewan St. John Smith · 2025 · eLife
43. Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines
    Hongqing Zhang, Yanan Zhang, Cheng‐Lin Deng, Qin-Xuan Zhu, Zhe-Rui Zhang, Xiaodan Li, Zhiming Yuan, Bo Zhang · 2024 · Molecular Therapy
44. Restoring hematopoietic stem and progenitor cell function in Fancc mice by in situ delivery of RNA lipid nanoparticles
    Omar A. Banda, Sarah E. Adams, Linah Omer, Seul K Jung, Hooda Said, Theerapat Phoka, Ying K. Tam, Drew Weissman, Stefano Rivella, Mohamad‐Gabriel Alameh et al. · 2024 · Molecular Therapy — Nucleic Acids
45. A replicating RNA vaccine protects against severe fever with thrombocytopenia syndrome virus infection in mice
    Allie Stamper, Thomas C. Bisom, Kimberly D. Meade-White, Matthew C. Lewis, Shanna S. Leventhal, Chad S. Clancy, Troy C. Hinkley, Jesse H. Erasmus, Heinz Feldmann, David W. Hawman · 2025 · npj Vaccines
46. Controlling Protein Expression by Delivery of RNA Therapeutics Using Lipid Nanoparticles
    Paulo J.C. Lin, Ying K. Tam · 2019 · Elsevier eBooks
47. A Self-Amplifying Human Papillomavirus 16 Vaccine Candidate Delivered by Tobacco Mosaic Virus-Like Particles
    Sweta Karan, Jessica Fernanda Affonso de Oliveira, Miguel A. Moreno‐Gonzalez, Nicole F. Steinmetz · 2024 · ACS Applied Bio Materials
48. A sort and sequence approach to dissect heterogeneity of response to a self-amplifying RNA vector in a novel human muscle cell line
    Rachel D. Barton, John S. Tregoning, Ziyin Wang, Daniel Gonçalves-Carneiro, Radhika Patel, Paul F. McKay, Robin J. Shattock · 2024 · Molecular Therapy — Nucleic Acids
49. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials
50. Targeted suppression of type 1 interferon signaling during RNA delivery enhances vaccine-elicited immunity
    Byungji Kim, Ryan Ramsey Hosn, Tanaka K. Remba, Jonathan Dye, Howard H. Mak, Jae Yun Jeong, Milton R. Cornwall-Brady, Wuhbet D. Abraham, Laura Maiorino, Mariane B. Melo et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
51. Aşı Teknolojisinde Yeni Umutlar: mRNA Aşıları
    Engin Yılmaz · 2021 · Mikrobiyoloji Bulteni
52. The Regulation of Nucleic Acid Vaccine Responses by the Microbiome
    Andrew M. F. Johnson, Kevin Hager, Mohamad‐Gabriel Alameh, Phuong Van, Nicole B. Potchen, Koshlan Mayer-Blackwell, Andrew J. Fiore-Gartland, Samuel S. Minot, Paulo J.C. Lin, Ying K. Tam et al. · 2023 · The Journal of Immunology
53. Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques
    Tiffany M. Styles, Akil Akhtar, Chunyang Gu, Gabriele Neumann, Hiromi Muramatsu, Justine S. McPartlan, Poulami Talukder, Derrik Gratz, Kasey Stokdyk, Hannah L. Turner et al. · 2025 · Cell Reports Medicine
54. A single ultra-low dose self-amplifying RNA rabies vaccine confers rapid and complete protection in mice
    Danhua Zhao, Geng Chen, Shanshan Wang, Yue Suo, Qiang Ye, Rui Xing, Yongjun Yang, Zhi Li, XuelianWang, Rui Zhou et al. · 2025 · Vaccine
55. Formulation and administration timing of lipid derivatized JAK-inhibitor and corticosteroid modulate saRNA-LNP inflammation and expression
    Nuthan Vikas Bathula, Irafasha C. Casmil, Josh J. Friesen, Endger Yuan, Suiyang Liao, Bappa Maiti, Jing‐Ping Liou, Mei-Jung Lai, Shyh‐Dar Li, Sam Chen et al. · 2026 · Journal of Controlled Release
56. Enhanced efficacy of a next-generation EEEV self-replicating RNA platform for combination cancer immunotherapies
    Shigeki Joseph Miyake-Stoner, Christian J. Maine, Annie C. Chou, Gabrielle P. Dailey, Darina S. Spasova, Christine C. Domingo, Jessica Sparks, Gaelle Genevieve Alice Picarda, Herbert Kim Lyerly, Erika J. Crosby et al. · 2026 · Molecular Therapy
57. Orthoflavivirus Vaccine Platforms: Current Strategies and Challenges
    Giulia Unali, Florian Douam · 2025 · Vaccines
58. Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA
    Louisa Zimmermann, Stephanie Erbar · 2024 · Methods in molecular biology
59. SARS-CoV-2 mRNA Vaccine Immunogenicity in Hemodialysis Patients: Promising Vaccine Protection That May Be Hindered by Fluid Overload
    Hedia Hebibi, Marvin A. Edeas, Laure Cornillac, Séverine Beaudreuil, Jedjiga Achiche, David Attaf, Samah Saibi, Charles Chazot, Fatah Ouaaz, Bernard Canaud · 2022 · Kidney and Dialysis
60. Evaluation of mRNA Transfection Reagents for mRNA Delivery and Vaccine Efficacy via Intramuscular Injection in Mice
    Jungho Kim, Jihyun Yang, Suhyeon Heo, Ha Ryoung Poo · 2025 · ACS Applied Bio Materials
61. The ability of alphavirus replicases to synthesize non-viral type I interferon-inducing RNAs correlates with viral RNA synthesis and has a diverse impact on virus replication and pathogenicity
    Ailar Omler, Anna Rutmane, Suresh Mahalingam, Andres Merits · 2026 · Journal of Virology
62. Safety of mRNA-Based Vaccines for SARS CoV-2
    Beatrice Barda, Andreas Cerny · 2021 · Chemical Research in Toxicology
63. The potential epidemic threat of Ebola virus and the development of a preventive vaccine
    Hongqing Zhang, Qiu‐Yan Zhang, Zhiming Yuan, Bo Zhang · 2023 · Journal of Biosafety and Biosecurity
64. Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes
    Reo Kanechi, Tatsuya Shishido, Mana Tachikawa, Tomohiro Nishimura, Akihito Sawada, Hayato Okade, Daisuke Ishikawa, Hitoshi Yamaguchi, Marito Araki · 2025 · Biochemistry and Biophysics Reports
65. System Theoretic Methods in Drug Discovery and Vaccine Formulation: Review and Perspectives
    Ankita Sharma, Yen-Che Hsiao, Abhishek Dutta · 2025 · Drugs and Drug Candidates
66. Acute Thrombotic Thrombocytopenic Purpura: Rare and Life-Threatening Side Effect of Recent BNT-162b2 COVID-19 Vaccination
    Jay D. Patel, Muhammad Umair Jahngir, Ahmad Abdulzahir, Ismael Rodríguez · 2022 · HCA Healthcare Journal of Medicine
67. A comprehensive comparison between COVID-19 vaccines: a review
    Chi Wai Ng, Senrui Liang, Yuke Li · 2021
68. Ex vivo recapitulation of intramuscular mRNA vaccination with naïve and recall antigens using a human Lymphoid Follicle Chip platform
    Yunhao Zhai, Min‐Wen Ku, Ka Yang, Aditya Patil, Pranav Prabhala, Lirong He, Yuncheng Man, Sven B. Spörri, Supriya Gharpure, Abdul Rahman Isaacs et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
69. Regenerative Immunotherapy for Cancer: Transcription Factor Reprogramming of Tumor-Specific T Cells
    Tyler R. McCaw, Nicholas P. Restifo, Kathrin Plath, Joseph Garfield Crompton · 2025 · Cancers
70. A Host Cell Vector Model for Analyzing Viral Protective Antigens and Host Immunity
    Sun-Min Ahn, Jin-Ha Song, Seung-Eun Son, H. K. Kim, Gun Kim, Seung-Min Hong, Kang-Seuk Choi, Hyuk‐Joon Kwon · 2025 · International Journal of Molecular Sciences
71. Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough
    Vijay Kumar Mishra, Abhigyan Ranjan, Yachana Mishra · 2025 · Exploration of Immunology
72. GenIV vaccines: bridging innovation to equity in neglected tropical diseases
    Marta Araújo, Dhiraj Gurjar, Nicolas Grandchamp, Bhaskar Saha, Ricardo Silvestre · 2026 · Frontiers in Immunology
73. Polymeric Delivery System for mRNA Therapeutics: Design Principles and Recent Advances
    Sidi Bao, Irene Rose Reuben, Josie Ward, Wenxin Wang, X Wang · 2026 · Genes
74. In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform
    Yunhao Zhai, Min‐Wen Ku, Ka Yang, Aditya Patil, Pranav Prabhala, Liqun He, Yuncheng Man, Mizanur Rahman, Kavya Menon, Sven B. Spörri et al. · 2026 · iScience
75. Adjuvants, the Elephant in the Room for RNA Vaccines
    Sigrid D’haese, Sabine den Roover, Joeri L. Aerts · 2022 · RNA technologies
76. Introduction
    Siguna Mueller · 2022 · Springer eBooks
77. Mechanism of mRNA vaccine, current study and direction of development
    Kai Wang · 2024 · Theoretical and Natural Science
78. Exploring Immune Responses through Dynamic Modeling of Cell‐Immune Interactions in Viral Infection and Vaccination
    Kwang Su Kim, Il Hyo Jung, Jong Hyuk Byun · 2024 · Complexity
79. Integrating Context of Tumor Biology and Vaccine Design to Shape Multidimensional Immunotherapies
    Nathaniel S. Wang, Christian J. Maine · 2020 · Future Drug Discovery
80. COVID-19 as milestone for the use of new vaccine types
    Milan Marković · 2020 · Hrana i ishrana
81. pDNA and mRNA vaccines
    Kanwal Gill, Leanne Minall, Aslin Rodríguez Nassif · 2021 · Elsevier eBooks
82. Differential clearance rate of proteins encoded on a self-amplifying mRNA vaccine in muscle and lymph nodes
    Reo Kanechi, Tatsuya Shishido, Mana Tachikawa, Tomohiro Nishimura, Akihito Sawada, Hayato Okade, Daisuke Ishikawa, Hitoshi Yamaguchi, Marito Araki · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
83. Cap-independent co-expression of dsRNA-sensing and NF-κB pathway inhibitors enables tunable self-amplifying RNA expression with reduced immunotoxicity
    Tony K.Y. Lim, Anne Ritoux, Luke W Paine, Larissa Ferguson, Tawab Abdul, Laura J Grundy, Ewan St. John Smith · 2025 · eLife
84. mRNA Vaccine: An Advanced and Transformative Technology for Vaccine Development
    Vikas Kushwaha, Anuprabha, R.C. Sobti · 2021 · Springer eBooks
85. Vacinas baseadas em RNA mensageiro formuladas em nanopartículas lipídicas para tratamento de tumores induzidos pelo HPV-16.
    Jamile Ramos da Silva · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
86. Appraisal of Some of the Key Postulates Underlying mRNA Vaccines
    Siguna Mueller · 2022 · Springer eBooks
87. Relevance for mRNA Vaccine Safety
    Siguna Mueller · 2022 · Springer eBooks
88. The Focused Analysis of COVID-19 RNA-based vaccines
    Qingrong Li, Jiayi Wu · 2023 · Highlights in Science Engineering and Technology
89. Genetic-Based Vaccine Vectors
    David B. Weiner, Kathrin Ute Jansen, Tonya L. Villafana · 2023 · Elsevier eBooks
90. A First-Principles Approach to Decode the Interferon Response to MRNA-Based Vaccines in Antigen Presenting Cells
    Federica Vanone, Lorena Leonardelli, Luca Marchetti, Gianluca Selvaggio · 2024 · SSRN Electronic Journal
91. Modeling factors affecting the design and manufacture of the recombinant vaccine: Key points for health policymakers and professionals
    Mohammadkarim Bahadori, Mohammad Mohammadian, Mohsen Abbasi Farajzadeh, Ramin Ravangard · 2024 · International Journal of Healthcare Management
92. Chemokine dynamics after mRNA vaccination
    L. Marques Palma, Sebastian Schlaweck, Chrystel Flores, Hasan Murat Aslan, Christian Kurts, Peter Brossart, Janine Becker-Gotot, Annkristin Heine · 2026 · Immunology Letters
93. mRNA vaccines: the next frontier in disease prevention
    Quratul ain Babar, Maryam Maryam, ALI MUSTAPHA MUHAMMAD, Muhammad Farrukh Tahir, Anwar Mohamed Ali · 2024 · Elsevier eBooks
94. mRNA Vaccines: Unlocking Potential, Exploring Applications, and Envisioning Future Horizons
    Gaurav Mishra, Sunny Rathee, Munish Garg, Umesh Kumar Patil · 2025 · Current Drug Delivery
95. Broad-spectrum immune suppression encoded in self-amplifying RNA enables non-cytotoxic, non-immunostimulatory, externally controllable transgene expression
    Tony K.Y. Lim, Anne Ritoux, Luke W Paine, Larissa Ferguson, Tawab Abdul, Ewan St. John Smith · 2025 · eLife
96. Self-amplifying mRNA expression is governed by mitochondrial machinery and ACSL4
    Lara F. Tshering, Chong Wang, Qing Xiang, Sharmistha Kundu, Alicia Solórzano, Javier F. Chaparro‐Riggers, Laura Lin, Azadeh Paksa · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
97. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
    Saweta Garg, Mangaljeet Singh, Amy Dann, Reshu Sanan, Sadafara Pillai, Marloes Peeters, Pankaj Singla · 2025 · Elsevier eBooks
98. mRNA-based vaccines: Rational antigen design, delivery optimization, and immune modulation
    Shengbin Liu, Haixing Shi, Danni Dai, Tingchen Tian, Xing Duan, Ju Sun, Weitong Xu, Xiaoling Yin, Yongmei Xie, Xiangrong Song · 2025 · Chinese Chemical Letters
99. Transcriptional effects of influenza virus M1 and NP gene expression in DF-1 cells and their immunogenicity in cognate B21 chickens
    Sun-Min Ahn, Ho-Won Kim, Minji Kim, S. Lim, Hyeon-Jin Sa, Seung-Ji Kim, H. W. Park, Kang-Seuk Choi, Hyuk‐Joon Kwon · 2026 · BMC Veterinary Research
100. Safety and HBsAg reduction with a lentiviral vaccine J-51 in chronic hepatitis B: An investigator-initiated pilot trial
     Jieyu Song, Qiran Zhang, Yumeng Zhang, Jingjing Shen, Rongrong Wei, Kun Wang, Chunyan Shen, Wenjuan Wang, Mingmei Chu, Fang Zhou et al. · 2026 · Molecular Therapy Advances